According to the research report titled ‘Global Fertility Services Market (2022 Edition) - Analysis By Procedure, Patients, End User, By Region, By Country (2022 Edition): Market Insights, and Forecast with Impact of COVID-19 (2022-2027)’, available with MarketStudyReport, global fertility services market was worth USD 17.45 billion in 2021 and is anticipated to showcase a notable CAGR during 2022-2027.

Report findings suggests that factors such as rising rate of male infertility, prevalence of PCOS (polycystic ovary syndrome) among females, cases of premature ovarian failure, and improvement in insurance coverage for IVF procedures are the major growth determinants for global fertility services market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5164672/  

Furthermore, increasing awareness of infertility treatments, developments in assisted reproductive technologies, and surging number of fertility clinics across the globe are slated to augment market outlook in the coming years.

Moreover, soaring number of same-sex couples, growing usage of IVF services to support pregnancy, increasing government funding for the emergence of innovative IVF solutions, growing disposable income of individuals, and shifting trend toward having children later in life are also anticipated to propel market growth during the forecast period.

However, high cost of treatment, low success rate for IVF procedures, incidences of congenital abnormalities, and side effects of IVF have hampered the industry expansion in the recent past.

On the basis of end-user terrain, worldwide fertility services marketplace is classified into hospitals, clinical institute research, fertility clinics, and others. In terms of patients, the industry is branched into male, female, and others. Based on procedure, the market is divided into surrogacy, IVF, and others.

Regionally speaking, the latest industry trends are studied across North America (U.S., Canada), Europe (UK, Italy, France, Germany), Asia Pacific (China, South Korea, India, Japan).

Seasoned analysts cite that the United States industry holds major revenue share at present, due to growing use of IVF procedures by the regional population. Also, Europe market is gaining traction currently, owing to rising incidences of obesity problems in the region.

Boston IVF, Monash IVF Group, Cook Medical Inc., CooperSurgical Fertility Solutions, Progyny Inc., FUJIFILM Irvine Scientific Inc., Celmatix Inc., INVO Bioscience Inc., San Diego Fertility Center, Thermo Fisher Scientific Inc., and Merck KGaA are the leading players in global fertility services market.